Regencell Bioscience Holdings Limited (RGC)
NCM · Drug Manufacturers - Specialty & Generic
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Peers in Drug Manufacturers - Specialty & Generic
All in industry →Takeda Pharmaceutical Company Limited
Zoetis Inc.
Haleon plc
Teva Pharmaceutical Industries Limited
United Therapeutics Corporation
Viatris Inc.
Neurocrine Biosciences, Inc.
Elanco Animal Health Incorporated
Dr. Reddy's Laboratories Limited
Alkermes plc
Recent press releases
March 2026
Regencell Bioscience Holdings Ltd — 6-K Filing
# 🧾 What This Document Is This is a "current report" (Form 6-K) filed with the SEC. It's not a routine earnings report. Think of it as an important, timely announcement from Regencell. The core news is that the company has set up a financing tool to sell up to **$500 million** of its stock over tim
SEC filings
All filings →Insider trades
All insider trades →Regencell Bioscience Holdings Limited has no reported insider trades in the last 90 days.